nexvax2
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00879749)
Timeline
Indications
Mechanism of action
- Unspecified targetImmunity, desensitized
immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nexvax2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03644069 | Phase 2 | Aug 6, 2018 | ImmusanT, Inc. |
| NCT03543540 | Phase 1 | May 1, 2018 | ImmusanT, Inc. |
| NCT02528799 | Phase 1 | Aug 1, 2015 | ImmusanT, Inc. |
| NCT00879749 | Phase 1 | Apr 1, 2009 | Monash University, Nexpep Pty Ltd, University of Sydney |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImmusanT, Inc. | For profit | 3 | 3 | 2 | 2015 |
| Monash University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Nexpep Pty Ltd | For profit | 1 | 1 | 1 | 2009 |
| University of Sydney | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1